Provided by Tiger Fintech (Singapore) Pte. Ltd.

Orchestra BioMed

4.08
+0.24006.25%
Post-market: 4.080.00000.00%16:23 EDT
Volume:43.60K
Turnover:175.43K
Market Cap:155.10M
PE:-2.55
High:4.13
Open:3.93
Low:3.88
Close:3.84
Loading ...

Company Profile

Company Name:
Orchestra BioMed
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
56
Office Location:
150 Union Square Drive,New Hope,Pennsylvania,United States
Zip Code:
18938
Fax:
- -
Introduction:
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Directors

Name
Position
Roderick Wong
President, Chief Executive Officer and Chairman
Naveen Yalamanchi
Executive Vice President, Chief Financial Officer and Director
Carsten Boess
Director
Michael Brophy
Director
Pedro Granadillo
Director
Stuart Peltz
Director

Shareholders

Name
Position
Naveen Yalamanchi
Executive Vice President, Chief Financial Officer and Director
Alice Lee
Vice President of Operations, Secretary and Treasurer
Stephanie A. Sirota
Vice President of Corporate Strategy and Corporate Communications